Evidence map›Paper›PMID 42884178›Full record

ArticleInternational journal of molecular sciences2026

CD180-Associated B-Cell Alterations in Type 1 Diabetes and the In Vitro Effects of Chlorogenic Acid: An Integrated Transcriptomic and Experimental Study.

Zihang Wang, Arzu Mijit, Rong Han, Mengjia Li, Yang Wu, Lufeng Cheng

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zihang WangSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Arzu MijitSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Rong HanSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Mengjia LiSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
Yang WuSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.ORCID 0000-0001-6505-2643
Lufeng ChengSchool of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.

Funding

National Natural Science Foundation of China 82460730Science and Technology Department of Xinjiang Uyghur Autonomous Region 2024A03004Xinjiang Uygur Autonomous Region Department of Science and Technology 2024TSYCLJ0034Xinjiang Uygur Autonomous Region Education Department XJ2025G192
6 · The paper itself

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease involving progressive loss of pancreatic β-cells. Although B cells have been implicated in T1DM progression, the molecular characteristics associated with disease-related B-cell states remain unclear. Here, we investigated B-cell-associated molecular alterations in T1DM and explored the potential immunomodulatory effects of a natural compound. Public T1DM transcriptomic datasets were analyzed using differential expression analysis, WGCNA, and machine-learning approaches. Single-cell RNA sequencing was used to characterize

Indexed as

Antigens, CDB-LymphocytesChlorogenic AcidDiabetes Mellitus, Type 1TranscriptomeAnimalsFemaleGene Expression ProfilingHumansInsulin-Secreting CellsMiceMice, Inbred NODMolecular Docking SimulationAntigens, CDChlorogenic AcidB cellsCD180chlorogenic Acidimmune regulationtype 1 diabetes

Identifiers

PMID42884178
PMCPMC13666279

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.